Open-House-Originale-Rabattverträge 2026-14 Crizotinib
Tender Summary
The Techniker Krankenkasse in Germany from Europe region has released this tender for The participating health insurance funds aim to conclude discount agreements with all suitable pharmaceutical companies for the active ingredient crizotinib, in accordance with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V). The agreements will be concluded within the framework of the participating health insurance funds Open-House Originals procedure: individual negotiations regarding contract terms will not be conducted; uniform conditions will apply. The participating health insurance funds will not guarantee exclusivity to any individual contracting partner. The contract term is a maximum of 24 months, beginning on December 1, 2026. The contract will end no later than November 30, 2028, regardless of the contract date. If the patent expires or market exclusivity ends before the aforementioned end date, the contract will automatically terminate at the end of the month in which the patent expires or market exclusivity ends. Joining this Open-House Originals procedure is possible at any time during the contract term. All further information can be found in the participation and contract documents. with tender notice no. 693690-2026 published on 08 Oct 2026. The tender is due to expire on 30 Nov 2028. This tender is sourced from TED Europa and is eligible for suppliers interested in Pharmaceutical products. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 15354746.
Tender Details
Tender NoticeTI Ref: 15354746
Tender Notice No
693690-2026
Tender Organisation
Techniker Krankenkasse
Tender Sector
Tender Service
Worldwide
Tender Region
Tender Project Location
Tender CPV
33600000 : Pharmaceutical products
Tender Source
TED Europa
Tender Document Type
Competition
Tender Deadline
30 Nov 2028 783 days left
Tender Description
The participating health insurance funds aim to conclude discount agreements with all suitable pharmaceutical companies for the active ingredient crizotinib, in accordance with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V). The agreements will be concluded within the framework of the participating health insurance funds Open-House Originals procedure: individual negotiations regarding contract terms will not be conducted; uniform conditions will apply. The participating health insurance funds will not guarantee exclusivity to any individual contracting partner. The contract term is a maximum of 24 months, beginning on December 1, 2026. The contract will end no later than November 30, 2028, regardless of the contract date. If the patent expires or market exclusivity ends before the aforementioned end date, the contract will automatically terminate at the end of the month in which the patent expires or market exclusivity ends. Joining this Open-House Originals procedure is possible at any time during the contract term. All further information can be found in the participation and contract documents.
Tender Bidding Type
Tender Document
Unlock Full Details — Register Free
Already have an account? Log in to download the tender document.
Frequently Asked Questions About This Tender
Who has issued this tender, and what is it for?
The tender has been issued by Techniker Krankenkasse in Germany. Such a type of tender falls under Pharmaceutical products, within the Oil and Gas sector, and is listed on Tender Impulse under notice number 693690-2026.
What are the key dates for this tender?
The notice was published on 08 Oct 2026 and submissions close on 30 Nov 2028. Late bids are rarely accepted in public procurement, so aim to have your documents ready several days before the closing date.
Which CPV codes apply to this tender?
It is classified under CPV codes 33600000, which correspond to Pharmaceutical products. If your company supplies these products or services, these are the codes to save in your alert profile so no matching tender passes you by.
Can I submit my bid for this tender to Tender Impulse?
No - and this matters. Tender Impulse is a tender aggregation and alert service: we collect procurement notices from official sources around the world and list them in one place. We do not receive, forward or evaluate bids. Your bid for this tender must be submitted directly to Techniker Krankenkasse, using the method described in the original tender document, before 30 Nov 2028. Tender Impulse provides complete assistance in submitting all bids posted on its website.
How do I get the bid documents and participation details?
Request a live demo on Tender Impulse and our tender experts will walk you through this listing, share the available documents, and explain how to submit your bid to Techniker Krankenkasse. Subscribers also receive help with registration requirements and, where needed, translation of non-English notices - but the submission itself always goes from you to the buyer.
How can I find more tenders like this in Germany?
There are currently 32069 live tenders of 560258 total tenders from Germany on Tender Impulse. You can browse them on our Germany tenders page, or save a search combining Germany with CPV codes 33600000 - we will then email you every new match on the day it is published.
How to prepare for this bid?
Suppliers must verify technical specifications, the delivery schedules and any other intrinsic details as provided in the complete bid documents before deciding to submit their bids. All necessary certifications and supplier registrations must be undertaken before participation.
Is this tender beneficial for me?
The procurement is applicable to companies in the Pharmaceutical products and related industries. If you belong to this industry, you can review the technical documents before assessing your relevance to your company.
What is the procurement trend for Open-House-Originale-Rabattvertrge 2026-14 Crizotinib?
The public procurement trends for Open-House-Originale-Rabattvertrge 2026-14 Crizotinib can be assessed by viewing historical data and buying patterns for this product. Subscribed members can view and even download reports of tenders released in the past for their market research. This shall allow them to carefully prepare a compelling bid.
Explore More Pharmaceutical products Tenders in Germany, Europe Region and Worldwide
Looking for more tenders like this one in Pharmaceutical products? With millions of global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Oil and Gas sector in Germany, or expanding across regions, we provide live, accurate and relevant updates every day.
Our platform sources tenders from national and local government portals, international development and funding agencies, municipal corporations, state authorities, NGOs, education ministries and public-private partnerships.
Daily Tender Updates Across 190+ Countries
Every day we add hundreds of new RFPs, RFQs, EOIs and contract awards across multiple sectors and geographies. This tender from Germany is just a sample of what's available right now - there are currently 32,069 live Germany tenders to explore.
Search Smarter with CPV and Industry Matching
Each listing is categorised using CPV codes such as 33600000, enabling precise filtering by tender type, location, industry, deadline and issuing organisation.
Start Your Tender Journey
Request a free live demo to unlock tenders customised to your sector, country and CPV categories - with alerts, documents and submission support.
